{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:34:16Z","timestamp":1783942456090,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,31]]},"DOI":"10.7759\/cureus.72752","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T11:08:34Z","timestamp":1730372914000},"source":"Crossref","is-referenced-by-count":2,"title":["Forecasting Daily Radiotherapy Patient Volumes in a Tertiary Hospital Using Autoregressive Integrated Moving Average (ARIMA) Models"],"prefix":"10.7759","author":[{"given":"Thanarpan","family":"Peerawong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaichulee","family":"Chaichulee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasuree","family":"Sangsupawanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.05.014","article-title":"Radiotherapy utilization in developing countries: an IAEA study","volume":"128","author":"Rosenblatt E","year":"2018","unstructured":"Rosenblatt E, Fidarova E, Zubizarreta EH, et al.. Radiotherapy utilization in developing countries: an IAEA study. Radiother Oncol. 2018, 128:400-5. 10.1016\/j.radonc.2018.05.014","journal-title":"Radiother Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2014.11.002","article-title":"Intensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced lung cancer","volume":"25","author":"Chang JY","year":"2015","unstructured":"Chang JY. Intensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced lung cancer. Semin Radiat Oncol. 2015, 25:110-6. 10.1016\/j.semradonc.2014.11.002","journal-title":"Semin Radiat Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial","volume":"35","author":"Chun SG","year":"2017","unstructured":"Chun SG, Hu C, Choy H, et al.. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial. J Clin Oncol. 2017, 35:56-62. 10.1200\/JCO.2016.69.1378","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11816","article-title":"Xerostomia and clinical outcomes in definitive intensity modulated radiotherapy (IMRT) versus three-dimensional conformal radiotherapy (3D-CRT) for head and neck squamous cell carcinoma: a meta-analysis","volume":"34","author":"DE Felice F","year":"2020","unstructured":"DE Felice F, Pranno N, Papi P, Brugnoletti O, Tombolini V, Polimeni A. Xerostomia and clinical outcomes in definitive intensity modulated radiotherapy (IMRT) versus three-dimensional conformal radiotherapy (3D-CRT) for head and neck squamous cell carcinoma: a meta-analysis. In Vivo. 2020, 34:623-9. 10.21873\/invivo.11816","journal-title":"In Vivo"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/21457.8583","article-title":"Toxicity profile of IMRT vs. 3D-CRT in head and neck cancer: a retrospective study","volume":"10","author":"Ghosh G","year":"2016","unstructured":"Ghosh G, Tallari R, Malviya A. Toxicity profile of IMRT vs. 3D-CRT in head and neck cancer: a retrospective study. J Clin Diagn Res. 2016, 10:XC01-3. 10.7860\/JCDR\/2016\/21457.8583","journal-title":"J Clin Diagn Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-011-2273-z","article-title":"Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial","volume":"187","author":"Budach W","year":"2011","unstructured":"Budach W, B\u00f6lke E, Fietkau R, et al.. Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial. Strahlenther Onkol. 2011, 187:449-60. 10.1007\/s00066-011-2273-z","journal-title":"Strahlenther Onkol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-8-26","article-title":"Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: a planning study","volume":"8","author":"Holt A","year":"2013","unstructured":"Holt A, Van Gestel D, Arends MP, et al.. Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: a planning study. Radiat Oncol. 2013, 8:26. 10.1186\/1748-717X-8-26","journal-title":"Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.meddos.2012.10.009","article-title":"Clinical experience transitioning from IMRT to VMAT for head and neck cancer","volume":"38","author":"Studenski MT","year":"2013","unstructured":"Studenski MT, Bar-Ad V, Siglin J, Cognetti D, Curry J, Tuluc M, Harrison AS. Clinical experience transitioning from IMRT to VMAT for head and neck cancer. Med Dosim. 2013, 38:171-5. 10.1016\/j.meddos.2012.10.009","journal-title":"Med Dosim"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12831","article-title":"Estimating radiotherapy demands in South East Asia countries in 2025 and 2035 using evidence-based optimal radiotherapy fractions","volume":"14","author":"Yahya N","year":"2018","unstructured":"Yahya N, Roslan N. Estimating radiotherapy demands in South East Asia countries in 2025 and 2035 using evidence-based optimal radiotherapy fractions. Asia Pac J Clin Oncol. 2018, 14:e543-7. 10.1111\/ajco.12831","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2014.10.005","article-title":"Evidence-based estimates of the demand for radiotherapy","volume":"27","author":"Delaney GP","year":"2015","unstructured":"Delaney GP, Barton MB. Evidence-based estimates of the demand for radiotherapy. Clin Oncol (R Coll Radiol). 2015, 27:70-6. 10.1016\/j.clon.2014.10.005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2013.05.006","article-title":"The Malthus Programme: developing radiotherapy demand models for breast and prostate cancer at the local, regional and national level","volume":"25","author":"Round C","year":"2013","unstructured":"Round C, Mee T, Kirkby NF, Cooper T, Williams MV, Jena R. The Malthus Programme: developing radiotherapy demand models for breast and prostate cancer at the local, regional and national level. Clin Oncol (R Coll Radiol). 2013, 25:538-45. 10.1016\/j.clon.2013.05.006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12199-012-0294-6","article-title":"An overview of health forecasting","volume":"18","author":"Soyiri IN","year":"2013","unstructured":"Soyiri IN, Reidpath DD. An overview of health forecasting. Environ Health Prev Med. 2013, 18:1-9. 10.1007\/s12199-012-0294-6","journal-title":"Environ Health Prev Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08696-6","article-title":"Forecasting lung cancer incidence, mortality, and prevalence to year 2030","volume":"21","author":"Jakobsen E","year":"2021","unstructured":"Jakobsen E, Olsen KE, Bliddal M, Hornbak M, Persson GF, Green A. Forecasting lung cancer incidence, mortality, and prevalence to year 2030. BMC Cancer. 2021, 21:985. 10.1186\/s12885-021-08696-6","journal-title":"BMC Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.31557\/apjec.2021.4.1.3-7","article-title":"Forecasting the incidence of breast, colorectal and bladder cancers in north of Iran using time series models; comparing Bayesian, Arima and bootstrap approaches","volume":"4","author":"Janbabaee G","year":"2021","unstructured":"Janbabaee G, Nadi-Ghara A, Afshari M, et al.. Forecasting the incidence of breast, colorectal and bladder cancers in north of Iran using time series models; comparing Bayesian, Arima and bootstrap approaches. Asian Pacific J Environm Cancer. 2021, 4:3-7. 10.31557\/apjec.2021.4.1.3-7","journal-title":"Asian Pacific J Environm Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3843","article-title":"Epidemiological characteristics and forecasting incidence for patients with breast cancer in Shantou, Southern China: 2006-2017","volume":"10","author":"Lin H","year":"2021","unstructured":"Lin H, Shi L, Zhang J, Zhang J, Zhang C. Epidemiological characteristics and forecasting incidence for patients with breast cancer in Shantou, Southern China: 2006-2017. Cancer Med. 2021, 10:2904-13. 10.1002\/cam4.3843","journal-title":"Cancer Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1460458220983878","article-title":"Prediction of cancer incidence rates for the European continent using machine learning models","volume":"27","author":"Sekeroglu B","year":"2021","unstructured":"Sekeroglu B, Tuncal K. Prediction of cancer incidence rates for the European continent using machine learning models. Health Inform J. 2021, 27:1460458220983878. 10.1177\/1460458220983878","journal-title":"Health Inform J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2022.06.029","article-title":"Forecasting of overall and aggressive prostate cancer incident counts at the small area level","volume":"211","author":"Wah W","year":"2022","unstructured":"Wah W, Papa N, Ahern S, Earnest A. Forecasting of overall and aggressive prostate cancer incident counts at the small area level. Public Health. 2022, 211:21-8. 10.1016\/j.puhe.2022.06.029","journal-title":"Public Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18105069","article-title":"Forecasting of lung cancer incident cases at the small-area level in Victoria, Australia","volume":"18","author":"Wah W","year":"2021","unstructured":"Wah W, Stirling RG, Ahern S, Earnest A. Forecasting of lung cancer incident cases at the small-area level in Victoria, Australia. Int J Environ Res Public Health. 2021, 18:5069. 10.3390\/ijerph18105069","journal-title":"Int J Environ Res Public Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2013.14.3.2097","article-title":"Statistical modelling and forecasting of cervix cancer cases in radiation oncology treatment: a hospital based study from Western Nepal","volume":"14","author":"Sathian B","year":"2013","unstructured":"Sathian B, Fazil A, Sreedharan J, et al.. Statistical modelling and forecasting of cervix cancer cases in radiation oncology treatment: a hospital based study from Western Nepal. Asian Pac J Cancer Prev. 2013, 14:2097-100. 10.7314\/apjcp.2013.14.3.2097","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref20","article-title":"Time Series Forecasting in Python","author":"Marco Peixeiro","year":"2020","unstructured":"Marco Peixeiro. Time Series Forecasting in Python. Manning, New York, NY; 2020."},{"key":"ref21","unstructured":"PyCaret. an open source, low-code machine learning library in Python. (2020). Accessed: April 29, 2020: https:\/\/www.pycaret.org."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e117","article-title":"Implications of radiotherapy utilization in Korea from 2010 to 2019","volume":"36","author":"Lee J","year":"2021","unstructured":"Lee J, Kim WC, Yoon WS, Rim CH. Implications of radiotherapy utilization in Korea from 2010 to 2019. J Korean Med Sci. 2021, 36:e117. 10.3346\/jkms.2021.36.e117","journal-title":"J Korean Med Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/0971-6203.103602","article-title":"Image-guided radiation therapy: physician's perspectives","volume":"37","author":"Gupta T","year":"2012","unstructured":"Gupta T, Narayan CA. Image-guided radiation therapy: physician's perspectives. J Med Phys. 2012, 37:174-82. 10.4103\/0971-6203.103602","journal-title":"J Med Phys"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/0146645318764092","article-title":"The need for, and implementation of, image guidance in radiation therapy","volume":"47","author":"Ibbott GS","year":"2018","unstructured":"Ibbott GS. The need for, and implementation of, image guidance in radiation therapy. Ann ICRP. 2018, 47:160-76. 10.1177\/0146645318764092","journal-title":"Ann ICRP"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5603\/RPOR.a2022.0032","article-title":"Radiotherapy during the COVID-19: a review about management and treatment strategies","volume":"27","author":"Bernabucci L","year":"2022","unstructured":"Bernabucci L, Cornacchione P, Boldrini L, et al.. Radiotherapy during the COVID-19: a review about management and treatment strategies. Rep Pract Oncol Radiother. 2022, 27:291-302. 10.5603\/RPOR.a2022.0032","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6231","article-title":"What did COVID-19 pandemics teach us about single-fraction radiotherapy for painful bone metastases-state of the art or undertreatment?","volume":"12","author":"Arsenijevi\u0107 T","year":"2023","unstructured":"Arsenijevi\u0107 T, Stepanovi\u0107 A, Milo\u0161evi\u0107-Mara\u010di\u0107 B, Popari\u0107-Bandjur B, Mi\u0161kovi\u0107 I, Gavrilovi\u0107 D, Nikitovi\u0107 M. What did COVID-19 pandemics teach us about single-fraction radiotherapy for painful bone metastases-state of the art or undertreatment?. Cancer Med. 2023, 12:15912-21. 10.1002\/cam4.6231","journal-title":"Cancer Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2022.05.019","article-title":"Change in the use of fractionation in radiotherapy used for early breast cancer at the start of the COVID-19 pandemic: a population-based cohort study of older women in England and Wales","volume":"34","author":"Gannon MR","year":"2022","unstructured":"Gannon MR, Dodwell D, Miller K, et al.. Change in the use of fractionation in radiotherapy used for early breast cancer at the start of the COVID-19 pandemic: a population-based cohort study of older women in England and Wales. Clin Oncol (R Coll Radiol). 2022, 34:e400-9. 10.1016\/j.clon.2022.05.019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1202544","article-title":"A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis","volume":"13","author":"Gil GO","year":"2023","unstructured":"Gil GO, de Andrade WP, Diniz PH, et al.. A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis. Front Oncol. 2023, 13:1202544. 10.3389\/fonc.2023.1202544","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/293910-forecasting-daily-radiotherapy-patient-volumes-in-a-tertiary-hospital-using-autoregressive-integrated-moving-average-arima-models","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T11:08:37Z","timestamp":1730372917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/293910-forecasting-daily-radiotherapy-patient-volumes-in-a-tertiary-hospital-using-autoregressive-integrated-moving-average-arima-models"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.72752","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}